Katilyn Knutson

Alterations in the Immune Cell Composition in Premalignant Breast Tissue that Precede Breast Cancer Development.

Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy.

IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian Cancer.

Immune checkpoint inhibition by anti-PDCD1 (anti-PD1) monoclonal antibody has significant therapeutic activity against central nervous system lymphoma in an immunocompetent preclinical model.

CD56+ immune cell infiltration and MICA are decreased in breast lobules with fibrocystic changes.

Downregulation of TAP1 and TAP2 in early stage breast cancer.

Sodium channel Na1.3 is important for enterochromaffin cell excitability and serotonin release.

Macrophagic "Crown-like Structures" Are Associated with an Increased Risk of Breast Cancer in Benign Breast Disease.

Cancer immunotherapy beyond immune checkpoint inhibitors.

Next generation of immune checkpoint therapy in cancer: new developments and challenges.

Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer Patients.

Recurrent fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract.

Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer.

A population of gut epithelial enterochromaffin cells is mechanosensitive and requires Piezo2 to convert force into serotonin release.